July 24, 2014 3:19 PM ET

Pharmaceuticals

Company Overview of Barr Pharmaceuticals, Inc.

Executive Profile

Philip Andrew Gioia

President of North America & Global API Business, Glenmark Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships
----

Background

Mr. Philip Andrew Gioia is the President of North America & Global API Business at Glenmark Pharmaceuticals Ltd. since December 2, 2013. Mr. Gioia was the Senior Vice President of Generic Sales and Marketing at Barr Pharmaceuticals, Inc. Mr. Gioia served as the Vice President of Proprietary Sales at Barr Laboratories Inc. Prior to joining Barr Laboratories Inc. in 1995, Mr. Gioia served as Product Manager with Forest Laboratories Inc. Prior to Forest, he worked with ...

Corporate Headquarters

225 Summit Avenue
Montvale, New Jersey 07645

United States

Phone: 201-930-3300
Fax: 201-930-3330

Board Members Memberships

Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Arun Sawhney B.Com., P.G.D.B.M.Managing Director, Chief Executive Officer, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee, Member of Science Committee, Member of Quality & Integrity Committee and Member of Corporate Social Responsibility Committee
Ranbaxy Laboratories Ltd.
$122.7M
Arthur S. Przybyl Chief Executive Officer, President and Director
ANI Pharmaceuticals, Inc.
$400.5K
Arthur P. Bedrosian J.D.Chief Executive Officer, President, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$437.5K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Barr Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.